Bessemer Group
RDY icon

Bessemer Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Bessemer Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9M Buy
1,857,221
+33,936
+2% +$458K 0.04% 268
2026
Q1 		$25.3M Buy
1,823,285
+403,219
+28% +$5.61M 0.04% 258
2025
Q4 		$19.9M Buy
1,420,066
+69,078
+5% +$969K 0.03% 282
2025
Q3 		$18.9M Buy
1,350,988
+318,621
+31% +$4.58M 0.03% 266
2025
Q2 		$15.5M Buy
1,032,367
+168,487
+20% +$2.41M 0.03% 280
2025
Q1 		$11.4M Buy
863,880
+81,024
+10% +$1.12M 0.02% 286
2024
Q4 		$12.4M Buy
782,856
+72,901
+10% +$1.1M 0.02% 298
2024
Q3 		$11.3M Buy
709,955
+34,135
+5% +$549K 0.02% 306
2024
Q2 		$10.3M Buy
675,820
+282,935
+72% +$4.06M 0.02% 312
2024
Q1 		$5.76M Buy
+392,885
New +$5.74M 0.01% 368
2021
Q1 		– Sell
-1,585
Closed -$23K – 1615
2020
Q4 		$23K Buy
+1,585
New +$21.3K ﹤0.01% 1159
2016
Q4 		– Sell
-805
Closed -$7K – 2029
2016
Q3 		$7K Buy
+805
New +$7.69K ﹤0.01% 1582

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bessemer Group's RDY Position: Q2 2026 in Review

Bessemer Group increased its Dr. Reddy's Laboratories (RDY) stake by 1.9% in Q2 2026, buying an estimated $458K and bringing the position to 1,857,221 shares worth $26.9M. The position accounts for 0.04% of the portfolio, ranked #268.

Bessemer Group first reported a position in RDY in Q3 2016 and has held it in 12 quarters since. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Bessemer Group held 1,857,221 shares of Dr. Reddy's Laboratories worth $26.9M as of Q2 2026.
  • Bessemer Group bought 33,936 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $458K.
  • Dr. Reddy's Laboratories made up 0.04% of Bessemer Group's portfolio in Q2 2026, its #268 holding.
  • Bessemer Group first reported a position in Dr. Reddy's Laboratories in Q3 2016 and has held it in 12 quarters since.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.